Thyroid Carcinoma, Anaplastic
4 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Conventional Surgery + Intensity-Modulated Radiation Therapy + Quality-of-Life Assessment + Trametinib + PEMBROLIZUMAB + DABRAFENIB for thyroid carcinoma, anaplastic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| dabrafenib/trametinib for thyroid carcinoma, anaplastic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Selective coverage radiotherapy for thyroid carcinoma, anaplastic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Trametinib + DABRAFENIB for thyroid carcinoma, anaplastic | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |